ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
CytomX Therapeutics Inc

CytomX Therapeutics Inc (CTMX)

1,07
-0,06
(-5,31%)
Geschlossen 28 Dezember 10:00PM
1,0601
-0,0099
( -0,93% )
Vor Marktöffnung: 3:14PM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
1,0601
Gebot
1,06
Fragen
1,12
Volumen
17.518
0,00 Tagesbereich 0,00
0,833 52-Wochen-Bereich 5,85
Marktkapitalisierung
Handelsende
1,07
Handelsbeginn
-
Letzter Handelszeitpunkt
15:15:36
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
1.178.791
Ausgegebene Aktien
78.258.879
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-146,58
Gewinn pro Aktie (EPS)
-0,01
Erlöse
101,21M
Nettogewinn
-569k

Über CytomX Therapeutics Inc

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company which is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platform. The company probody technology platform to create proprietary cancer immunotherapies against clini... CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company which is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platform. The company probody technology platform to create proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of unique conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues. The company focuses on developing Probody therapeutics which addresses clinically-validated cancer targets in immuno-oncology that are difficult to drug and lead to concerns about damage to healthy tissues or toxicities. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Dover, Delaware, USA
Gegründet
-
CytomX Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CTMX. The last closing price for CytomX Therapeutics was US$1,07. Over the last year, CytomX Therapeutics shares have traded in a share price range of US$ 0,833 to US$ 5,85.

CytomX Therapeutics currently has 78.258.879 shares in issue. The market capitalisation of CytomX Therapeutics is US$83,74 million. CytomX Therapeutics has a price to earnings ratio (PE ratio) of -146.58.

CTMX Neueste Nachrichten

CytomX Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Nov. 27, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that...

CytomX Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

- Phase 1a dose escalation for CX-904 (EGFR-CD3 PROBODY® T-cell engager) continues to advance. Potential Phase 1b initiation in 2025. - - Phase 1 study of CX-2051 (EpCAM PROBODY® ADC) in advanced...

CytomX Therapeutics to Report Third Quarter 2024 Financial Results on November 7, 2024

SOUTH SAN FRANCISCO, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologic therapeutics, today...

CytomX Therapeutics Announces First Patient Dosed with CX-801, a Dually-Masked Interferon-Alpha 2b PROBODY®, in a Phase 1 Study in Patients with Solid Tumors

SOUTH SAN FRANCISCO, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologic therapeutics, today...

CytomX Therapeutics to Present at Upcoming September Investor Conferences

SOUTH SAN FRANCISCO, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0199-1.842592592591.081.15951.0412836371.08885127CS
40.03012.922330097091.031.42118447421.18378523CS
12-0.0899-7.817391304351.151.420.83311787911.10374363CS
26-0.1499-12.38842975211.211.520.8339362291.17222077CS
52-0.5299-33.32704402521.595.850.83323903143.17396831CS
156-3.4099-76.28411633114.475.850.83314997172.65381621CS
260-7.4399-87.52823529418.515.440.83311832823.7514981CS

CTMX - Frequently Asked Questions (FAQ)

What is the current CytomX Therapeutics share price?
The current share price of CytomX Therapeutics is US$ 1,0601
How many CytomX Therapeutics shares are in issue?
CytomX Therapeutics has 78.258.879 shares in issue
What is the market cap of CytomX Therapeutics?
The market capitalisation of CytomX Therapeutics is USD 83,74M
What is the 1 year trading range for CytomX Therapeutics share price?
CytomX Therapeutics has traded in the range of US$ 0,833 to US$ 5,85 during the past year
What is the PE ratio of CytomX Therapeutics?
The price to earnings ratio of CytomX Therapeutics is -146,58
What is the cash to sales ratio of CytomX Therapeutics?
The cash to sales ratio of CytomX Therapeutics is 0,83
What is the reporting currency for CytomX Therapeutics?
CytomX Therapeutics reports financial results in USD
What is the latest annual turnover for CytomX Therapeutics?
The latest annual turnover of CytomX Therapeutics is USD 101,21M
What is the latest annual profit for CytomX Therapeutics?
The latest annual profit of CytomX Therapeutics is USD -569k
What is the registered address of CytomX Therapeutics?
The registered address for CytomX Therapeutics is 850 NEW BURTON ROAD, SUITE 201, KENT, DOVER, DELAWARE, 19904
What is the CytomX Therapeutics website address?
The website address for CytomX Therapeutics is www.cytomx.com
Which industry sector does CytomX Therapeutics operate in?
CytomX Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
AALAmerican Airlines Group Inc
US$ 17,34
(0,00%)
271,28k
AAGRAfrican Agriculture Holdings Inc
US$ 0,1326
(0,00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 69,73
(0,00%)
0
AADIAadi Bioscience Inc
US$ 3,21
(0,00%)
3,82k
AACGATA Creativity Global
US$ 0,762551
(0,00%)
0
AALAmerican Airlines Group Inc
US$ 17,34
(0,00%)
271,28k
AAGRAfrican Agriculture Holdings Inc
US$ 0,1326
(0,00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 69,73
(0,00%)
0
AADIAadi Bioscience Inc
US$ 3,21
(0,00%)
3,82k
AACGATA Creativity Global
US$ 0,762551
(0,00%)
0
NXUNXU Inc
US$ 0,2434
(0,00%)
122,23M
WATTEnergous Corporation
US$ 0,4112
(0,00%)
65,17M
VINCVincerx Inc
US$ 0,194
(0,00%)
27,72M
INTZIntrusion Inc
US$ 2,16
(0,00%)
26,19M
SMXSMX Security Matters Public Company
US$ 0,3536
(0,00%)
25,31M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht